Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-25

FDA Approved: TIZANIDINE HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for tizanidine hydrochloride by Nivagen Pharmaceuticals, Inc., representing a regulatory update for this generic product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tizanidine hydrochloride (Tizanidine hydrochloride)

Snippet

SUPPL AP for TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE)